A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist

A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist

Vitiligo is a complex disease wherein derangements in multiple pathways determine the loss of functional melanocytes. Since its pathogenesis is not yet completely understood, vitiligo lacks a definitive safe and efficacious treatment. At present, different therapies are available; however, each moda...

Full description

Bibliographic Details
Main Authors: Federica Papaccio, Barbara Bellei, Monica Ottaviani, Andrea D’Arino, Mauro Truglio, Silvia Caputo, Giovanni Cigliana, Lorenzo Sciuto, Emilia Migliano, Alessia Pacifico, Paolo Iacovelli, Mauro Picardo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cells
Subjects:
vitiligo
PPARγ
pioglitazone
melanocytes
fibroblasts
cellular metabolism
Online Access:https://www.mdpi.com/2073-4409/11/22/3583

Internet

https://www.mdpi.com/2073-4409/11/22/3583

Similar Items